{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T11:33:25Z","timestamp":1648726405459},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1995,2,1]],"date-time":"1995-02-01T00:00:00Z","timestamp":791596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1995,2]]},"DOI":"10.1007\/bf00877748","type":"journal-article","created":{"date-parts":[[2004,12,28]],"date-time":"2004-12-28T00:33:35Z","timestamp":1104194015000},"page":"85-88","source":"Crossref","is-referenced-by-count":1,"title":["Intravenous cibenzoline in the management of acute supraventricular tachyarrhythmias"],"prefix":"10.1007","volume":"9","author":[{"given":"Paul","family":"Bru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Cointe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Paganelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Ricard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"L\ufffdvy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1476-5381.1982.tb09163.x","volume":"75","author":"JS Millar","year":"1982","unstructured":"Millar JS, Vaughan-Williams EM. Effects on rabbit nodal, atrial, ventricular and Purkinje cell potentials of a new anti-arrhythmic drug cibenzoline which protects against action potential shortening in hypoxia.Br J Pharmacol 1982;75:469?478.","journal-title":"Br J Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-0736(84)80020-5","volume":"17","author":"M Kushner","year":"1984","unstructured":"Kushner M, Magiros E, Peters R, Carliner N, Plotnick G, Fischer M. The electrophysiologic effects of oral cibenzoline.J Electrocardiol 1984;17:15?24.","journal-title":"J Electrocardiol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0002-8703(86)90271-1","volume":"112","author":"P Touboul","year":"1986","unstructured":"Touboul P, Atallah G, Kirkorian G, et al. The electrophysiologic effects of cibenzoline in humans related to dose and plasma concentration.Am Heart J 1986;112:333?339.","journal-title":"Am Heart J"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0735-1097(84)80265-X","volume":"3","author":"KF Browne","year":"1984","unstructured":"Browne KF, Prystowsky EN, Zipes DP, Chilson DA, Heger JJ. Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmias.J Am Coll Cardiol 1984;3:857?864.","journal-title":"J Am Coll Cardiol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0735-1097(84)80228-4","volume":"4","author":"JB Kostis","year":"1984","unstructured":"Kostis JB, Krieger S, Moreyra A, Cosgrove N. Cibenzoline for treatment of ventricular arrhythmias: A double-blind placebo-controlled study.J Am Coll Cardiol 1984;4:372?377.","journal-title":"J Am Coll Cardiol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0002-8703(85)90646-5","volume":"109","author":"DS Miura","year":"1985","unstructured":"Miura DS, Keren G, Torres V, Butler B, Aogaichi A, Somberg JC. Antiarrhythmic effects of cibenzoline.Am Heart J 1985;109:827?833.","journal-title":"Am Heart J"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/0002-9149(86)90841-6","volume":"57","author":"RC Klein","year":"1986","unstructured":"Klein RC, Horwitz LD, Rushforth N. Efficacy and safety of oral cibenzoline for ventricular arrhythmias.Am J Cardiol 1986;57:592?597.","journal-title":"Am J Cardiol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0002-9149(86)90735-6","volume":"57","author":"ST Rothbart","year":"1986","unstructured":"Rothbart ST, Saksena S. Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia.Am J Cardiol 1986;57:941?946.","journal-title":"Am J Cardiol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/01.CIR.75.4.800","volume":"75","author":"AA Seals","year":"1987","unstructured":"Seals AA, Haider R, Leon C, et al. Antiarrhythmic efficacy and hemodynamic effects of cibenzoline in patients with non-sustained ventricular tachycardia and left ventricular dysfunction.Circulation 1987;75:800?808.","journal-title":"Circulation"},{"key":"CR10","first-page":"327","volume":"38","author":"P Desoutter","year":"1983","unstructured":"Desoutter P, Duffour A, Aymard MF, Haiat R. Etude pharmacocin\u00e9tique d'un nouvel antiarythmique, la cibenzoline, \u00e0 la phase aig\u00fce d'un infarctus myocardique. Corr\u00e9lations th\u00e9rapeutiques.Th\u00e9rapie 1983;38:327?245.","journal-title":"Th\u00e9rapie"},{"issue":"Suppl 1","key":"CR11","first-page":"39","volume":"77","author":"P Pfitzner","year":"1988","unstructured":"Pfitzner P, Manz M, Luderitz B. Cibenzolin: Electrophysiologische Wirkungen bei Wolff-Parkinson-White Syndrom und AV-Knoten-Reentrytachykardie.Zeitschr Kardiol 1988;77(Suppl 1):39.","journal-title":"Zeitschr Kardiol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/oxfordjournals.eurheartj.a061849","volume":"6","author":"A Waleffe","year":"1985","unstructured":"Waleffe A, Duffour A, Aymard MF, Kulbertus H. Electrophysiologic effects and antiarrhythmic activity and pharmacokinetics of cibenzoline studied with programmed stimulation of the heart in patients with supraventricular reentrant tachycardias.Eur Heart J 1985;6:253?260.","journal-title":"Eur Heart J"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0378-4347(00)80955-X","volume":"273","author":"MR Hackman","year":"1983","unstructured":"Hackman MR, Lo Lee T, Brooks MA. Determination of cibenzoline in plasma and urine by high-performance liquid chromatography.J Chromatogr 1983;273:347?356.","journal-title":"J Chromatogr"},{"key":"CR14","first-page":"29","volume":"74","author":"S L\u00e9vy","year":"1981","unstructured":"L\u00e9vy S. Effects \u00e9lectrophysiologiques des antiarythmiques. Leur valeur pr\u00e9dictive des effets th\u00e9rapeutiques.Arch Mal Coeur 1981;74:29?35.","journal-title":"Arch Mal Coeur"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/oxfordjournals.eurheartj.a061897","volume":"6","author":"JJ Goy","year":"1985","unstructured":"Goy JJ, Greie M, Hurni M, Finci L, Duc J, Sigwart J. Conversion of supraventricular arrhythmias to sinus rhythm using flecainide.Eur Heart J 1985;6:518?524.","journal-title":"Eur Heart J"},{"key":"CR16","first-page":"413","volume":"14","author":"D Metz","year":"1990","unstructured":"Metz D, Chapoutot L, Chabert JP, et al. Cibenzoline IV versus fl\u00e9ca\u00efnide IV dans la r\u00e9duction des fibrillations auricularies spontan\u00e9es d'installation r\u00e9cente.L'information Cardiologique 1990;14:413?416.","journal-title":"L'information Cardiologique"},{"key":"CR17","unstructured":"Gursoy S, Atie J, Steurer G, Willems H, Andries E, Brugada P. Electrophysiologic effects of intravenous cibenzoline in idiopathic atrial flutter in man.Eur Heart J 1991;337(abstr. P1743)."},{"key":"CR18","unstructured":"Haiat R, Aymard MF, Dufour A. La cibenzoline intraveineuse dans le traitement des troubles du rythme supraven-triculaires et ventriculaires.Arch Mal Coeur 1985;sp\u00e9cial edition:95?97."},{"key":"CR19","first-page":"19","volume":"2","author":"P Lacombe","year":"1982","unstructured":"Lacombe P, Cointe R, Metge M, Bru P, Gerard R, L\u00e9vy S. Intravenous flecainide in the management of acute supraventricular tachyarrhythmias.J Electrophysiol 1982;2:19?22.","journal-title":"J Electrophysiol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/hrt.44.5.602","volume":"44","author":"CE Robertson","year":"1980","unstructured":"Robertson CE, Miller HC. Extreme tachycardia complicating the use of disopyramide in atrial flutter.Br Heart J 1980;44:602?603.","journal-title":"Br Heart J"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00877748.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00877748\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00877748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T12:57:25Z","timestamp":1556542645000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00877748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["BF00877748"],"URL":"https:\/\/doi.org\/10.1007\/bf00877748","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}